Live Free Webinar | Tuesday, October 3 | 10 AM & 5 PM CEST |
“SPRi and examples of Alzheimer’s disease investigation and circulating antibodies bioassay optimization”
REGISTER NOW !
| Event Overview This webinar will show the potentialities of the new multiplexing and fully automated SPRi “XelPleX” by illustrating two examples of the simultaneous characterization of multiple biologically relevant interactions. The first example represents the discovery and the study of the interaction between the endogenous antimicrobial peptide cathelicidin (LL37) and different beta-amyloid aggregation forms spotted onto the SPRi chip surface. This study, performed in collaboration with Stanford University, University of Pavia and CNR, confirms that cathelicidin is a binding partner of beta-amyloid and suggests its potential role as inhibitor of beta-amyloid fibrils. (link to the published article) |
Key Learning Objectives
|
Who Should Attend?
|
| Duration: 30 mins, followed by live Q&A |
| Presented by | ||
|
Dr Renzo Vanna, Researcher at LABION, IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy |
|
| Moderated by | ||
|
Dr Chiraz Frydman, SPRi Product Manager at HORIBA Scientific |
